SNOA · CIK 0001367083 · FY2026 live · 2026-03-31
Sonoma Pharmaceuticals, Inc.
View as
Model
Classic Z
FY2026
−18.54
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−18.54
Z″ −44.40
Score −18.54 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.521.2 × = 0.62X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−14.401.4 × = −20.16X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.183.3 × = −0.58X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.280.6 × = 0.17X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
1.401 × = 1.40
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.
Meridian Rank
9.73
from 9
0–100 · Classic Z family
Book standing
4
Year change
—
Market PD
—
O-score
25
Events on this name
Same published rows as Today.
No published events on this print.
Overview
rule-v1
Sonoma Pharmaceuticals, Inc. is on classic Z at −18.54 (distress) for FY2026, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 7th percentile in Healthcare.
- INKTDistressMiNK Therapeutics, Inc.−18.57
- LFWDDistressLifeward Ltd.−18.73
- CLGNDistressCollPlant Biotechnologies Ltd−18.27
- ANIXDistressAnixa Biosciences Inc−19.00
- NKTRDistressNEKTAR THERAPEUTICS−19.03
- RVPHDistressREVIVA PHARMACEUTICALS HOLDINGS, INC.−19.07
- JAGXDistressJaguar Health, Inc.−19.09
- ABUSDistressArbutus Biopharma Corp−17.93
Filing line items
Current assets
$12M
Total assets
$14M
Current liabilities
$5M
Total liabilities
$11M
Working capital
$7M
Retained earnings
−$201M
EBIT
−$2M
Total sales
$20M
Book equity
$3M
Accession 0001683168-26-004871. Live rank is the latest 10-K on EDGAR (FY2026, period 2026-03-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.